Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma

Clinical Cancer Research

Volumn 2, Issue 2, 1996, Pages 295-302

  Jakubowski, Ann A ^a   Bajorin, Dean F ^a   Templeton, Mary Agnes ^a   Chapman, Paul B ^a   Cody, Beverly V ^a   Thaler, Howard ^a   Tao, Yue ^a   Filippa, Daniel A ^a   Williams, Linda ^a   Sherman, Matthew L ^b   Garnick, Marc B ^b   Houghton, Alan N ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; RECOMBINANT COLONY STIMULATING FACTOR 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MELANOMA; METASTASIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 9044254523     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Tushinski, R. J., Oliver, I. T., Guilbert, L. J , Tynan, P. W , and Warner, J. R Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell, 28. 71-81, 1982.
2. Rambaldi, A., Young, D. C., and Griffin, J. D. Expression of the M-CSF (CSF-1) gene by human monocytes Blood, 69. 1409-1413, 1987.
3. Bagby, G. C , McCall, E , and Layman, D. L Regulation of colony-stimulating activity production: interactions of fibroblasts, mononuclear phagocytes, and lactoferrin J. Clin. Invest., 71. 340-344, 1983.
4. Bartocci, A., Mastrogiannis, D. S., Migliorati, G., Stockert, R. J., Wolkoff, A W., and Stanley, E. R. Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proc. Natl. Acad Sci. USA, 84: 6179-6183, 1987.
5. Sherr, C. J , Rettermier, C. W , Sacca, R., Roussel, M. F., Look, A. T., and Stanley, E. R. The c-fms protooncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell, 41: 665-676, 1985.
6. Sherr, C J., Roussel, M. F , and Rettenmier, C. W Colony stimulating factor-1 receptor (c-fms) J. Cell Biochem., 38: 179-187, 1988.
7. Weiner, L. M., Li, W., Holmes, M., Catalano, R. B., Dovnarsky, M., Padavic, K., and Alpaugh, R. K. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant γ-interferon: toxicity, monocytosis, and clinical effects. Cancer Res., 54: 4084-4090, 1994.
8. Minasian, L. M., Yao, T. J., Steffens, T. A., Scheinberg, D. A., Williams, L., Reidel, E., Houghton, A. N., and Chapman, P. B. A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma. Cancer (Phila.), 75: 2251-2257, 1995.
9. Ralph, P., and Nakoing, I. Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-1. Cell. Immunol., 105: 270-279, 1987.
10. Thomassen, M. J., Barna, B. P., Wiedemann, H. P., and Ahmad, M. Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor. J. Biol. Response Mod., 9: 87-91, 1990.
11. Munn, D. H., and Cheung, N-K. V. Antibody dependent antitumor cytoxicity by human monocytes cultured with recombinant macrophage colony stimulating factor induction of efficient antibody-mediated antitumor cytoxicity not detected by isotope release assays. J. Exp. Med., 170: 511-526, 1989.
12. Munn, D. H., Garnick, M. B., and Cheung, N-K. V. Effects of parenteral recombinant macrophage colony-stimulating factor on monocyte number, phenotype and antitumor cytoxicity in non-human primates. Blood, 75: 2042-2048, 1990.
13. Garnick, M. B., Stoudemire, J., Donahue, R. E., Metzger, M., Bree, A., Timony, G., Wong, G., Munn, D., and Cheung, N-K. V. In vitro and in vivo biological effects of recombinant human macrophage colony stimulating factor (rhM-CSF). Proc. Am. Soc. Clin. Oncol., 8: 184, 1989.
14. Ulich, T. R., del Castillo, J., Watson, L. R., Yin, S., and Garnick, M. B. In vivo hematologic effects of recombinant human macrophage colony-stimulating factor. Blood, 75: 846-850, 1990.
15. Bukowski, R. M., Budd, G. T., Gibbons, J. A., Bouer, R. J., Childs, A., Antal, J., Finke, J., Tusson, L., Lorenzi, V., McLain, D., Tubbs, R., Edinger, M., and Thomassen, M. J. Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects. J. Clin. Oncol., 12: 97-106, 1994.
16. Sanda, M. G., Yang, J. C., Topalian, S. L., Groves, E. S., Childs, A., Belfort, R., Jr., de Smet, M. D., Schwartzentruber, D. J., White, D. E., Lotze, M. T., and Rosenberg, S. A. Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study. J. Clin. Oncol., 10: 1643-1649, 1992.
17. Cole, D. J., Sanda, M. G., Yang, J. C., Schwartzentruber, D. J., Weber, J., Ettinghausen, S. E., Pockaj, B. A., Kim, H. I., Levin, R. D., Pogrebniak, H. W , Balkissoon, J., Fenton, R. M., DeBarge, L. R., Kaye, J., Rosenberg, S. A., and Parkinson, D. R. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer J. Natl. Cancer Inst., 86: 39-45, 1994.
18. Momin, F. A., Zalupski, M., Heilbrun, L. K., Flaherty, L , Fyfe, G., Baker, L. H., and Redman, B. G. Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcoma. J. Immunother., 16: 224-228, 1994.
19. Miller, A. B., Hoogstraten, B., Staquet, M., and Winkler, A. Reporting results of cancer treatment. Cancer (Phila.), 47: 207-214, 1981.
20. Real, F. X., Houghton, A. N., Albino, A. P., Cordon-Cardo, C., Melamed, M. R., Oettgen, H. F., and Old, L. J. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. Cancer Res., 45: 4401-4411, 1985.
21. Gernsheimer, T , Stratton, J., Ballem, P. J., and Slichter, S. J. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N. Engl. J. Med., 320: 974-980, 1989.
22. Redman, B. G., Flaherty, L., Chou, T. H., Kraut, M., Martino, S., Simon, M., Valdivieso, M., and Groves, E. Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancer. J. Immunother., 12: 50-54, 1992.
23. Zamkoff, K. W., Hudson, J., Groves, E. S., Childs, A., Konrad, M., and Rudolph, A. R. A phase I trial of recombinant human macrophage colony-stimulating factor by rapid intravenous infusion in patients with refractory malignancy. J. Immunother., 11: 103-110, 1991.
24. Nemunaitis, J., Meyers, J. D., Buckner, C. D., Shannon-Dorcy, K., Mori, M., Shulman, H., Bianco, J. A., Higano, C. S., Groves, E., Storb, R., Hansen, J., Appelbaum, F. P., and Singer, J. W. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood, 78: 907-913, 1991.
25. Stoudemire, J. B., and Garnick, M. B. Effects of recombinant human macrophage colony-stimulating factor on plasma cholsterol levels. Blood, 77: 750-755, 1991.
26. Parker, T. S., Levine, D. M., Donnelly, T. M., Stoudemire, J. B., and Garnick, M. B. Recombinant human macrophage colony stimulating factor (rhM-CSF) lowers LDL and raises HDL in WHHL rabbits. Circulation, 82 (Suppl. 3): 233a, 1990.
27. Sherman, M. L., Kaye, J. A., Schindler, J., Faulkner, R., Schaub, R. G., Tubridy, K. L., Kuca, B., and Garnick, M. B. Effects of recombinant human macrophage colony-stimulating factor (rhM-CSF) on cholesterol levels in healthy volunteers. Blood, 82 (Suppl.): 235a, 1993.
28. Nimer, S. D., Champlin, R. E., and Golde, D. W. Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor. J. Am. Med. Assoc., 260: 3297-3300, 1988.
29. Goldstein, J. L., Ho, Y. K., Basu, S. K., and Brown, M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA, 76: 333-337, 1979.
30. Schechter, I., Fogelman, A. M , Haberland, Seager, J., Hokom, M., and Edwards, P. A. The metabolism of native and malondialdehydge-altered low density lipoproteins by human monocyte-macrophages. J. Lipid Res., 22: 63-71, 1981.
31. Slater, H. R., Packard, C. J., and Shapard, J Receptor-independent catabolism of low density lipoprotein. J Biol. Chem., 257: 307-310, 1982.
32. Tabas, I., Weiland, D. A., and Tall, A. R. Unmodified low density lipoprotein causes cholesteryl ester accumulation in J774 macrophages. Proc. Natl. Acad. Sci. USA. 82: 416-420, 1985.
33. Clinton, S. K., Underwood, R., Hayes, L., Sherman, M. L., Kufe, D. W., and Libby, P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am. J. Pathol., 140: 301-316, 1992.
34. Sherman, M. L , Stein, E. A., Isaacsohn, J., Lees, R. S., and Garnick, M. B. Role of recombinant human macrophage colony-stimulating factor (rhM-CSF) in cholesterol metabolism and atherosclerosis. In: F. P. Woodford, J. Davignon, and A. Sniderman (eds.), Atherosclerosis, pp. 598-602. New York: Elsevier Science, 1995.
35. Peters, W. P., Kurtzber, J., Rao, M , Atwater, S., Coleman, R. E., Jones, R., Shpall, E., Ross, M., Affronti, M. L., Gilbert, C., and Garnick, M. Effects of recombinant human macrophage colony stimulating factor on hematopoiesis following high dose chemotherapy (HDC) and autologous bone marrow support (ABMS). Blood, 74 (Suppl.): 269a, 1989.
36. Garnick, M. B., and Stoudemire, J. B. Preclinical and clinical evaluation of recombinant human macrophage colony-stimulating factor (rhM-CSF). Int. J. Cell Cloning, 8 (Suppl. 1): 356-373, 1990.
37. Shadle, P. J., Allen, J. I., and Geier, M. D. Detection of endogenous macrophage colony-stimulating factor (M-CSF) in human blood. Exp. Hematol., 17: 154-159, 1989.
38. Moore, R. N , Oppenheim, J J., Farra, J. J., Carter, Jr., C. S., Waheed, A., and Shadduck, R. K. Production of lymphocyte-activating factors (interleukin 1) by macrophages activated with colony-stimulating factors. J. Immunol., 125: 1302-1305, 1980.
39. Warren, M. K., and Ralph, P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J. Immunol., 137: 2281-2285, 1986.